Literature DB >> 9820463

Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?

A S Levey1.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9820463     DOI: 10.1053/ajkd.1998.v32.pm9820463

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  18 in total

1.  Lipoprotein-apolipoprotein changes in renal transplant recipients.

Authors:  Maurizio Cassader; Gianluca Ruiu; Roberto Gambino; Natalina Alemanno; Giorgio Triolo; Fabrizio Veglia; Gianfranco Pagano
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

2.  Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.

Authors:  Min Ji Shin; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim; Harin Rhee; Naria Lee
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

3.  Change in cardiovascular risk factors with progression of kidney disease.

Authors:  Linda F Fried; Ronit Katz; Mary Cushman; Mark Sarnak; Michael G Shlipak; Lewis Kuller; Anne B Newman
Journal:  Am J Nephrol       Date:  2008-10-24       Impact factor: 3.754

4.  Impaired postprandial lipemic response in chronic kidney disease.

Authors:  Jeffrey M Saland; Lisa M Satlin; Jeanna Zalsos-Johnson; Serge Cremers; Henry N Ginsberg
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

Review 5.  End-stage renal disease and limb salvage.

Authors:  Houssam K Younes; Mark G Davies; Eric K Peden
Journal:  Methodist Debakey Cardiovasc J       Date:  2013-04

Review 6.  Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.

Authors:  Suree Lekawanvijit; Henry Krum
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

7.  In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients.

Authors:  Ayman El-Menyar; Mohammad Zubaid; Kadhim Sulaiman; R Singh; Hassan Al Thani; Mousa Akbar; Bassam Bulbanat; Rashed Al-Hamdan; Wael Almahmmed; Jassim Al Suwaidi
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

Review 8.  Sympathetic nervous system function in renal hypertension.

Authors:  Meryem Tuncel; Robert Augustyniak; Weiguo Zhang; Robert D Toto; Ronald G Victor
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 9.  Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes.

Authors:  Jay Garg; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

10.  Relationship between major adverse cardiac events and angiographic findings in dialysis patients.

Authors:  F Fabbian; G Cacici; V De Biase; T Yabarek; C Gangemi; L Franceschini; A De Giorgi; P Benussi; A Lupo; F Portaluppi
Journal:  Int Urol Nephrol       Date:  2010-09-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.